Recapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Organoids
Bing Zhao(Fudan University), Xinhua Lin(Fujian Medical University), Wei Xu(Beijing Geriatric Hospital), Jinsong Wei(Fudan University), Ran Gao(National Institute of Advanced Industrial Science and Technology), Junbo Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chao Ni(Wenzhou Medical University), Zhenghong Yuan(Shanghai Medical College of Fudan University), Xiaoyue Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Rong Zhang(Huazhong Agricultural University), Qisheng Zhang(Chemical Synthesis Lab), Li Yang(Cincinnati Children's Hospital Medical Center), Youhua Xie(Shanghai Medical College of Fudan University), Yuyan Wang(Yangtze University), Ting Lv(Guangxi University of Chinese Medicine), Jianqing Liang(Fudan University)
Cited by 22
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649